A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy

THE IMPACT OF NATIONAL CANCER ACT

Frankie A. Holmes, Ronald S. Walters, Richard L. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 803 citations

Medicine, Oncology, Pharmacology +10

Relationships between the structure of taxol analogs and their antimitotic activity

Françoise Guéritte-Voegelein, Daniel Guénard, François Lavelle et al. · Journal of Medicinal Chemistry · 1991 · 537 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.

Vicente Valero, Frankie A. Holmes, R S Walters et al. · Journal of Clinical Oncology · 1995 · 388 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

J.-M. Nabholtz, Karen A. Gelmon, M. Bontenbal et al. · Journal of Clinical Oncology · 1996 · 383 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

P. Ravdin, Howard A. Burris, Gary Cook et al. · Journal of Clinical Oncology · 1995 · 319 citations

Medicine, Oncology, Pharmacology +16